University of Colorado, Denver
Welcome,         Profile    Billing    Logout  
 35 Trials 
18 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Berman, Brian
NCT06771323: Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia

Not yet recruiting
2
20
US
Valbenazine, Placebo
Virginia Commonwealth University, Neurocrine Biosciences
Cervical Dystonia
01/26
01/26
NCT05157763: A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma

Recruiting
1/2
32
US
EscharEx 5% (EX-02 formulation), EX-02 5%
MediWound Ltd
Superficial Basal Cell Carcinoma, Nodular Basal Cell Carcinoma
05/22
06/22
CNXR-001D, NCT05279495: Double-Blind Study Determining the Efficacy of CannaXR in Decreasing UVA Premutagenic and Photoaging Markers

Completed
N/A
20
US
In a double-blinded fashion, 250 mg CANNAXR cream, TOPICAL CBD CANNAXR Cream, Topical VEHICLE cream
MINO Labs, LLC
Photoaging
04/23
05/23
Schwartz, Robert S
NCT04496518: Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

Active, not recruiting
N/A
2200
Europe, US
Intrinsic Antitachycardia Pacing (iATP) Therapy
Medtronic
Ventricular Tachycardia
01/25
01/27
NCT04489225: Personalized Therapy Study - HFRS (TriageHF) Post Approval Study

Active, not recruiting
N/A
2200
Europe, US
Observational
Medtronic
Heart Failure
01/25
01/27
ASQ, NCT04024943: Personalized Therapy Study - Attain Stability Quad Post-Approval Study

Active, not recruiting
N/A
1092
Europe, US
Quadripolar LV Lead, Medtronic CRT-P, Medtronic CRT-D
Medtronic
Heart Failure
01/27
04/27
NCT06048731: Enlighten Study: The EV-ICD Post Approval Registry

Recruiting
N/A
1000
Europe, Canada, US, RoW
Defibrillation using EV-ICD
Medtronic
Ventricular Arrhythmia, Tachycardia
05/30
10/37
Douglas, Ivor S
REPAVID-22, NCT05254990 / 2021-006951-32: Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

Terminated
3
409
Europe, US, RoW
Reparixin, Repertaxin L-lysine salt, Placebo, Matched placebo
Dompé Farmaceutici S.p.A
Infectious Pneumonia, Severe COVID-19
09/24
09/24
NCT05496868 / 2022-001612-25: Add-on Reparixin in Adult Patients With ARDS

Recruiting
2
66
Europe, US
Reparixin 600mg, REP, Matching Placebo, Control
Dompé Farmaceutici S.p.A, Dompè farmaceutici s.p.a.
Acute Respiratory Distress Syndrome, Adult
08/25
08/25
NCT06669403: OPT101 in Patients with Community Acquired Pneumonia (CAP) with Sepsis

Not yet recruiting
1
26
US
OPT101, Placebo, Placebeo
Op-T LLC
Sepsis, Community Acquired Pneumonia (CAP)
04/26
05/26
Wani, Sachin
NCT06693622: Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests

Recruiting
N/A
556
US
Patient survey
University of Colorado, Denver, American Society for Gastrointestinal Endoscopy, University of California, Los Angeles, University of Michigan, Exact Sciences Corporation, VA Medical Center-West Los Angeles, University of Texas Southwestern Medical Center
Gastro Esophageal Reflux Disease, Barrett Esophagus
03/29
03/29
Burton, James
PROTECT-V, NCT04870333 / 2020-004144-28: PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

Recruiting
2/3
5000
Europe
Niclosamide, Placebo, Ciclesonide, Sotrovimab
Cambridge University Hospitals NHS Foundation Trust, Life Arc, Kidney Research UK (KRUK), UNION therapeutics, Addenbrookes Charitable Trust, GlaxoSmithKline, National Institute for Health Research, United Kingdom
Covid19
07/24
12/24
ReliefCensus, NCT05524467: Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients

Completed
N/A
3100
Europe
Vifor (International) Inc.
Chronic Kidney Disease-associated Pruritus
01/24
01/24
Preston, Mary
NCT05002998: TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study

Active, not recruiting
4
313
Europe, US
Teprotumumab, TEPEZZA, Placebo, Saline Solution
Amgen
Thyroid Eye Disease
04/26
04/26
NCT04417530: Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Completed
2
22
US
AU-011, Suprachoroidal Microinjector, PDT Laser
Aura Biosciences
Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma
04/24
04/24
Tzou, Wendy
PLEA, NCT04216667: Posterior Wall And Left Atrial Appendage Empiric Electrical Isolation for Non-Paroxysmal Atrial Fibrillation

Terminated
N/A
124
Europe, US, RoW
Catheter ablation
Montefiore Medical Center, Biosense Webster, Inc.
Atrial Fibrillation
06/23
06/23
LESS-VT, NCT03490201: FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study

Completed
N/A
592
Europe, US, RoW
Market Approved RF Ablation System, FlexAbility SE Ablation Catheter
Abbott Medical Devices
Ventricular Tachycardia
04/24
04/24
IMPACT II, NCT04577859: Esophageal Protection Study: A Multicenter Study

Active, not recruiting
N/A
152
Europe, US
ensoETM. Esophageal cooling during AF ablation, Esophageal temperature monitoring probe
Advanced Cooling Therapy, Inc., d/b/a Attune Medical, University of Pennsylvania, Berry Consultants, Texas Cardiac Arrhythmia Research Foundation, Beth Israel Deaconess Medical Center, Kansas City Cardiac Arrhythmia Research LLC
AF - Atrial Fibrillation, Complication, Atrio-Esophageal Fistula
05/26
05/26
Sayer, w
No trials found
Colborn, Katie
No trials found
Caldwell, Ann E
No trials found
Yi, Jeniann
No trials found

Download Options